Kidney Diseases, Cystic - 23 Studies Found
Recruiting |
: A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe : Autosomal Dominant Polycystic Kidney Disease : 2016-07-21 |
Recruiting |
: Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease : ADPKD : 2016-05-04 : Other: water |
Not yet recruiting |
: The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain : Autosomal Dominant Polycystic Kidney Disease : 2016-04-08 : Device: Vessix Renal denervation using radio-ablation |
Recruiting |
: Efficacy of Tolvaptan on ADPKD Patients : Autosomal Dominant Polycystic Kidney Disease : 2016-03-11 : Drug: Tolvaptan |
Recruiting |
: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease : Polycystic Kidney Disease : 2015-10-30 :
|
Recruiting |
: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease : Polycystic Kidney, Autosomal Dominant : 2015-12-23 :
|
Active, not recruiting |
: Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101 : Autosomal Dominant Polycystic Kidney Disease (ADPKD) : 2015-11-24 : Drug: tesevatinib Other Name: KD019, XL647 |
Recruiting |
: Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) : Polycystic Kidney Disease : 2015-09-21 :
|
Completed |
: Effect of the Aquaretic Tolvaptan on Nitric Oxide System : Autosomal Dominant Polycystic Kidney Disease : 2015-02-18 :
|
Recruiting |
: The German ADPKD Tolvaptan Treatment Registry : ADPKD (Autosomal Dominant Polycystic Kidney Disease) : 2015-06-19 |